Arterial vein ECMO as support of cardiovascular function in the postoperative state of the child with a hypoplastic left heart
Vol. 38 (2021), Clinical Notes / Case Report
Vol. 38 (2021)

Arterial vein ECMO as support of cardiovascular function in the postoperative state of the child with a hypoplastic left heart

Clinical Notes / Case Report
Published 2021-03-17
Silvio Fabio Torres
Médico Pediatra Terapista Intensivo
PDF (Español (España))
HTML (Español (España))

Keywords

ECMO
Hypoplastyc left heart
neoaorta

Categories

How to Cite

1.
Torres SF. Arterial vein ECMO as support of cardiovascular function in the postoperative state of the child with a hypoplastic left heart. Rev Arg de Ter Int. [Internet]. 2021 Mar. 17 [cited 2024 Jul. 3];38. Available from: https://revista.sati.org.ar/index.php/MI/article/view/745
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Abstract

Summary

Introduction: Hypoplastic Left Heart Syndrome (HICHS) is defined as a serious birth defect characterized by underdevelopment of the left heart. Low cardiac output syndrome that is refractory to vasoactive drugs during the postoperative period can be an indication of venoarterial extracorporeal membrane oxygenation (ECMO).

Case: A child with HICHS and refractory inotropic support after Norwood Surgery was initiated on ECMO. She remained on ECMO during 4 days allowing the systemic ventricle to recover. She was extubated on the 22nd postoperative day and discharged from hospital 2 weeks later.

Discussion: ECMO in patients with univentricular physiology has been considered a contraindication. In this case without residual defects, ECMO support allowed time for the heart to recover.

 

Keywords: Hyploplastic left heart; ECMO; Neoaorta.

 

PDF (Español (España))
HTML (Español (España))

References

1. Reller, M.D., Strickland, M.J., Riehle-Colarusso, T., Mahle, W.T y Correa, A. (2008) Prevalence of congenital heart defects in metropolitan Atlanta, 1998-2005. The Journal of Pediatric, 153(6), 807-13.
2. Groisman, B., Bidondo, M.P., Barbero, P., Gili, J., y Liascovich, R. (2013). RENAC: Registro Nacional de Anomalías Congénitas de Argentina. Archivos argentinos de pediatría, 111(6), 484-494.
3. Samanek, M., Salavik, Z., y Zborilova, B. (1989) Prevalence, treatment, and outcome of heart disease in live-born children: a prospective analysis of 91,823 live-born children. Pediatric Cardiology, 10(4), 205-11.
4. Benson, D.W., Martin, L.J., y Lo, C.W. (2016) Genetics of Hypoplastic Left Heart Syndrome. The Journal of Pediatrics, 173, 25-31.

5. Graham, E.M., Bradley S., y Atz, A.M., (2005) Preoperative management of hypoplastic left heart síndrome. Expert Opinion on Pharmacotherapy, 6(5), 687-693.

6. Jolley, M., Yarlagadda, V.V., Rajagopal, S.K., Almodovar, M.C., Rycus, P.T., Thiagarajan, R.R.(2014) Extracorporeal membrane oxygenation-supported cardiopulmonary resuscitation following stage 1 palliation for hypoplastic left heart syndrome. Pediatric Critical Care Medicine. 15(6), 538-545

7. Sherwin, E D. et al. Extracorporeal membrane oxygenation after stage 1 palliation for hypoplastic left heart síndrome. The Journal of Thoracic and Cardiovascular Surgery, 144(6), 1337 – 1343
8. Alsoufi B, Shen I, Karamlou T, et al: Extracorporeal life support in neonates,
infants, and children after repair of congenital heart disease: Modern era results in a single institution. Ann Thorac Surg 2005; 80:15–21

The magazine does not retain the reproduction rights (copyright) so the authors can republish their works with the sole mention of the original publication source.